Immune Checkpoint Inhibitor PD-1 Pathway Is Down-Regulated in Synovium at Various Stages of Rheumatoid Arthritis Disease Progression

PLoS ONE - United States
doi 10.1371/journal.pone.0192704
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

PD-1 Checkpoint Inhibitor Associated Autoimmune Encephalitis

Case Reports in Oncology
Oncology
2017English

Time and Circumstances: Cancer Cell Metabolism at Various Stages of Disease Progression

Frontiers in Oncology
Cancer ResearchOncology
2016English

HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-Pd-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment

Journal of Cancer
Oncology
2020English

Direct Therapeutic Targeting of Immune Checkpoint PD-1 in Pancreatic Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Breast Care
SurgeryOncology
2016English

Rheumatoid Arthritis: Involvement of the Synovium in the Preclinical Phase?

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2011English

Analysis of Blimp-1 and PD-1/PD-L1 Immune Checkpoint in an Autoimmune Thyroiditis Animal Model

International Journal of Endocrinology
EndocrineEndocrinologyMetabolismAutonomic SystemsDiabetes
2020English

Is Rheumatoid Arthritis an Infectious Disease?

BMJ
1991English

The Role of PD-1/PD-L1 Signaling Pathway in Antitumor Immune Response

Klinicka Onkologie
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy